34 results
Page 2 of 2
6-K
EX-99.1
603bzpo bxot8
14 May 20
Sol-Gel Technologies Reports First Quarter 2020 Financial Results and Corporate Update
11:14am
6-K
EX-99.1
hhdvp
24 Mar 20
Sol-Gel Technologies Reports Full Year 2019 Financial Results and Corporate Update
4:38pm
6-K
EX-1.1
z96 2up5of4p89v
14 Feb 20
Sol-Gel Announces Pricing of Public Offering of Ordinary Shares and Warrants to Purchase
5:24pm
6-K
EX-99.1
mbpwsyp c5hyl
8 Jan 20
Sol-Gel Hosts Investor Call to Discuss Positive Results from Twyneo® Phase 3 Program in Acne Vulgaris
6:02am
6-K
EX-99.1
mh93pndg01l1ubr59he
30 Dec 19
Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of
7:40am
6-K
EX-99.1
1jdj4x9ro6ip7g
15 Nov 19
Sol-Gel Technologies Reports Third Quarter 2019 Financial Results and Corporate Update
9:02am
6-K
EX-1.1
sbp8bwk6k4pg8md
8 Aug 19
Sol-Gel Announces Pricing of Public Offering of Ordinary Shares
4:03pm
6-K
EX-99.2
owx6zzz1d3tb
25 Jul 19
Current report (foreign)
6:02am
6-K
EX-99.1
tq9 j40cyboau6
16 Apr 19
Current report (foreign)
8:25am
6-K
EX-99.1
wl2yxfga8glbnj p23
26 Dec 18
Sol-Gel Technologies Initiates Pivotal Phase III Clinical Program of TWIN for the Treatment of Acne Vulgaris
6:07am
20-F
90iiw
26 Mar 18
Annual report (foreign)
12:00am